Barry Ticho - 14 Aug 2026 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: STOK
Reported as of: 14 Aug 2026
Net transaction value: -$152,690
SEC form: 4
Accepted by SEC: 18 Aug 2026, 20:29:50 UTC
Prior SEC filing: 05 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Allan, Attorney-in-Fact

Key filing fact

Barry Ticho filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 18 Aug 2026.

Key facts

This page summarizes Barry Ticho's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2026, 20:29.

Change

Previous filing in this sequence was filed on 05 Aug 2026.
Current net transaction value: -$152,690.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780088 Primary reporting owner

Ticho Barry

Relationship: CHIEF MEDICAL OFFICER
Address: C/O STOKE THERAPEUTICS, INC., 45 WIGGINS AVENUE, BEDFORD
Signature: /s/ Jonathan Allan, Attorney-in-Fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,000
Change %: +49%
Price: $0.000000^*
Shares after: 30,422
Date: 14 Aug 2026
Ownership: Direct

STOK transaction

Common Stock

Sale

Transaction value: $144,833
Shares: -4,525
Change %: -15%
Price: $32.01
Shares after: 25,897
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F1, F2

STOK transaction

Common Stock

Sale

Transaction value: $7,857
Shares: -242
Change %: -0.93%
Price: $32.47
Shares after: 25,655
Date: 18 Aug 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STOK transaction Derivative

Performance Stock Units

Options Exercise

Transaction value
Shares: -10,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive.

Footnote F4

Each performance stock unit represents a right to receive one share of the Issuer's common stock.

Footnote F5

Achievement of this performance stock unit award was certified on August 14, 2025. Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.